245 related articles for article (PubMed ID: 25140035)
1. Identification of 9 serum microRNAs as potential noninvasive biomarkers of human astrocytoma.
Zhi F; Shao N; Wang R; Deng D; Xue L; Wang Q; Zhang Y; Shi Y; Xia X; Wang S; Lan Q; Yang Y
Neuro Oncol; 2015 Mar; 17(3):383-91. PubMed ID: 25140035
[TBL] [Abstract][Full Text] [Related]
2. Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas.
Yang C; Wang C; Chen X; Chen S; Zhang Y; Zhi F; Wang J; Li L; Zhou X; Li N; Pan H; Zhang J; Zen K; Zhang CY; Zhang C
Int J Cancer; 2013 Jan; 132(1):116-27. PubMed ID: 22674182
[TBL] [Abstract][Full Text] [Related]
3. The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma.
Zhi F; Chen X; Wang S; Xia X; Shi Y; Guan W; Shao N; Qu H; Yang C; Zhang Y; Wang Q; Wang R; Zen K; Zhang CY; Zhang J; Yang Y
Eur J Cancer; 2010 Jun; 46(9):1640-9. PubMed ID: 20219352
[TBL] [Abstract][Full Text] [Related]
4. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
5. Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li M; Zhou Y; Xia T; Zhou X; Huang Z; Zhang H; Zhu W; Ding Q; Wang S
Breast Cancer Res Treat; 2018 Jul; 170(2):257-270. PubMed ID: 29557526
[TBL] [Abstract][Full Text] [Related]
6. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
[TBL] [Abstract][Full Text] [Related]
8. Serum microRNA profiling in patients with glioblastoma: a survival analysis.
Zhao H; Shen J; Hodges TR; Song R; Fuller GN; Heimberger AB
Mol Cancer; 2017 Mar; 16(1):59. PubMed ID: 28284220
[TBL] [Abstract][Full Text] [Related]
9. miR-106a-5p inhibits the proliferation and migration of astrocytoma cells and promotes apoptosis by targeting FASTK.
Zhi F; Zhou G; Shao N; Xia X; Shi Y; Wang Q; Zhang Y; Wang R; Xue L; Wang S; Wu S; Peng Y; Yang Y
PLoS One; 2013; 8(8):e72390. PubMed ID: 24013584
[TBL] [Abstract][Full Text] [Related]
10. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
11. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
[TBL] [Abstract][Full Text] [Related]
12. Circulating serum oncologic miRNA in pediatric juvenile pilocytic astrocytoma patients predicts mural nodule volume.
Bookland M; Tang-Schomer M; Gillan E; Kolmakova A
Acta Neurochir (Wien); 2018 Aug; 160(8):1571-1581. PubMed ID: 29911246
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.
Zhang JX; Song W; Chen ZH; Wei JH; Liao YJ; Lei J; Hu M; Chen GZ; Liao B; Lu J; Zhao HW; Chen W; He YL; Wang HY; Xie D; Luo JH
Lancet Oncol; 2013 Dec; 14(13):1295-306. PubMed ID: 24239208
[TBL] [Abstract][Full Text] [Related]
14. Serum miR-483-5p: a novel diagnostic and prognostic biomarker for patients with oral squamous cell carcinoma.
Xu H; Yang Y; Zhao H; Yang X; Luo Y; Ren Y; Liu W; Li N
Tumour Biol; 2016 Jan; 37(1):447-53. PubMed ID: 26224475
[TBL] [Abstract][Full Text] [Related]
15. Identification of a four-microRNA panel in serum for screening renal cell carcinoma.
Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y
Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264
[TBL] [Abstract][Full Text] [Related]
16. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection.
Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J
Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients.
Zhang Y; Zhang Y; Yin Y; Li S
Pathol Res Pract; 2019 Aug; 215(8):152466. PubMed ID: 31146974
[TBL] [Abstract][Full Text] [Related]
19. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
20. Identification of plasma miR-106a-5p and miR-30a-5p as potential biomarkers for mesangial proliferative glomerulonephritis.
Wang L; Lin J; Yu T; Zuo Q; Shen B; Zhang H; Liu B; Cai D; Mao H; Zhao H; Zou Q; Xiao B
Clin Biochem; 2020 Oct; 84():79-86. PubMed ID: 32673627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]